Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proleukin and Rituxan in Low-Grade Non-Hodgkin's Lymphoma
NCT00045877Phase 3Completed
- Sponsor
- Chiron Corporation
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of aldesleukin in non-Hodgkin lymphoma (NHL), follicular lymphoma (FL), sponsored by Chiron Corporation. Status: completed.
02
Drugs
aldesleukin
03
Conditions
non-Hodgkin lymphoma (NHL)follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00045877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00045877.